Jeannine A Eberle

Title: Jeannine A Eberle: Innovator in Pharmaceutical Compounds

Introduction

Jeannine A Eberle is a prominent inventor based in Chatou, France. She has made significant contributions to the field of pharmaceuticals, particularly in the development of novel therapeutic agents. With a total of six patents to her name, Eberle's work focuses on compounds that possess various medicinal properties.

Latest Patents

Eberle's latest patents include innovative compounds such as Pyrimidin-6-yl acethydroxamic acids. These compounds are characterized by their unique formula, where R is aminocarbonylphenyl, and Ar is a phenyl group substituted with various functional groups. The compounds are synthesized through a specific reaction process involving 2-Ar-4-chloropyrimidin-6-yl ethylacetate and hydroxylamine hydrochloride. They exhibit a range of beneficial properties, including vasodilatatory, anti-ulcerous, and analgesic effects. Another notable patent involves 1-[2'-(α-Furoyl or α-thienoyl)eth-1'-yl]-2-(4'-cinnamyl), which serves as a therapeutic agent for treating conditions such as asthma and gastroduodenal ulcers.

Career Highlights

Eberle is associated with Delalande S.A., where she continues to innovate and develop new pharmaceutical solutions. Her work has been instrumental in advancing therapeutic options for various medical conditions. Eberle's dedication to research and development has positioned her as a key figure in her field.

Collaborations

Throughout her career, Eberle has collaborated with notable colleagues, including Claude P. Fauran and Guy M. Raynaud. These partnerships have contributed to the successful development of her patented compounds and have enhanced the impact of her work in the pharmaceutical industry.

Conclusion

Jeannine A Eberle is a distinguished inventor whose contributions to pharmaceutical compounds have significant implications for medical treatment. Her innovative work continues to pave the way for new therapeutic agents that address various health challenges.